![]() First of all, I'm happy on our progress with our new product introductions that they're going quite well. Let me just start with the things that I'm happy about when it comes to Q3. ![]() Thanks, Keri, and thanks everyone for joining us this morning. Bryan?īryan Hanson - Chairman, President and Chief Executive OfficerĪll right. With that, I'll now turn the call over to Bryan. Reconciliation of these measures to the most directly comparable GAAP financial measures is included within our Q3 earnings release, which can be found on our website,. Additionally, the discussions on this call will include certain non-GAAP financial measures. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties in addition to the inherent limitations of such forward-looking statements. ![]() Please note, we assume no obligation to update these forward-looking statements even if actual results or future expectations change materially. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Joining me today are Bryan Hanson, our Chairman, President and CEO and EVP and CFO, Suky Upadhyay. Welcome to Zimmer Biomet's Third Quarter 2021 Earnings Conference Call. ![]() Thank you, operator, and good morning, everyone.
0 Comments
Leave a Reply. |